Sort
50,496 grants matching “lung cancer”
Administrative Core
$909,968Roy S Herbst · Yale University · P50 · FY2018 · CA
Functional Analysis of Oncogenic Networks in Primary Organoids
$909,785Calvin J Kuo · Stanford University · U01 · FY2016 · CA
Human Monoclonal Antibodies Against Cancer
$909,717Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Inflammation Pathways and COPD in the Development of Lung Cancer
$909,096Ann G Schwartz · Wayne State University · R01 · FY2016 · CA
NRF Transcription Factors in Environmental Stress and Disease Intervention
$908,897Donna D Zhang · University Of Arizona · R35 · FY2023 · ES
3D Bioprinted lung cancer models for drug screening
$908,895Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Automatic SUV Extraction and Biodistribution Analysis of Preclinical PET
$908,835Alexander D. Klose · In Vivo Analytics, Inc. · R44 · FY2024 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$908,788Xihong Lin · Harvard School Of Public Health · R35 · FY2023 · CA
Determining the Fate of Transmembrane Proteins
$908,652Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Leadership, Planning and Evaluation (LP&E)
$908,501Michael A Teitell · University Of California Los Angeles · P30 · FY2025 · CA
Vaccine and radiation for the therapy of human cancers
$908,412James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$908,412James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mechanisms of Normal Tissue Toxicity
$908,372Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$907,746David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)
$907,661Jesse B Wolinsky · Fifth Base, Llc · R44 · FY2011 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$907,536Mary Christine Playdon · University Of Utah · U01 · FY2024 · CA
Development of a WNT Inhibitor for Advanced Stage Lung Cancer
$907,344Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2015 · CA
Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis
$907,219Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2009 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$906,613Claudine Isaacs · Georgetown University · N01 · FY2010 · CA
MMPA: A Novel Multiplexing Methylation Analysis Technology
$906,540Baochuan Guo · Glc Biotechnology, Inc. · R44 · FY2010 · CA
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$906,517Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESIS
$906,332Thomas Jefferson University · P01 · FY2004 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$906,300Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2024 · CA
Novel approaches to improve prediction of cancer-associated thrombosis
$905,594Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · HL
Effects of Expanded Coverage on Access, Health Care and Health in the South
$905,487John A. Graves · Vanderbilt University Medical Center · R01 · FY2015 · CA